• OPEN AN ACCOUNT
Indian Indices
Nifty
25,285.35 103.55
(0.41%)
Sensex
82,500.82 328.72
( 0.40%)
Bank Nifty
56,609.75 417.70
( 0.74%)
Nifty IT
35,609.05 -19.45
( -0.05%)
Global Indices
Nasdaq
46,372.36 -250.43
(-0.54%)
Dow Jones
6,754.41 -20.31
(-0.30%)
Hang Seng
48,192.70 -387.74
(-0.80%)
Nikkei 225
9,427.47 -81.93
(-0.86%)
Forex
USD-INR
88.77 0.03
(0.03%)
EUR-INR
103.17 -0.42
(-0.41%)
GBP-INR
118.97 -0.30
(-0.26%)
JPY-INR
0.58 -0.01
(-0.99%)

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524494
INE571A01038
271.6399623
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IPCALAB
37.39
33953.24
EPS(TTM)
Face Value()
Div & Yield %
35.79
1
0.3
 

Sampre Nutritions Ltd - Board Meeting Intimation for To Approve The Issue Of Bonus Shares And To Approve Sub-Division / Split Of Equity Shares
Sep 15,2025
Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2025 inter alia to consider and approve the sub-division / split of equity shares of the Company pursuant to the Section 61(1)(d) of the Companies Act 2013; and to issue bonus equity shares to the existing eligible members of the Company.